NDC codes

416497 NDC codes with hospital pricing data in the network.

• NDC 53436-0084-01 — Patiromer oral powder packet (8.4 g)AI (386 hospitals, 25,224–25,647 samples)
• NDC 60505-0564-01 — Brimonidine 0.15% eye dropsAI (253 hospitals, 24,801–25,647 samples)
• NDC 51672-1370-02 — Mupirocin 2% topical creamAI (136 hospitals, 24,801–25,647 samples)
• NDC 00574-7045-01 — Belladonna and opium rectal suppositoryAI (174 hospitals, 24,830–25,640 samples)
• NDC 00023-6153-01 — Oxybutynin 3.9 mg/24 hr patchAI (83 hospitals, 24,800–25,637 samples)
• NDC 00264-2304-10 — ACETIC ACID 0.25 % SOLUTIONAI (177 hospitals, 25,493–25,628 samples)
• NDC 63323-0241-20 — Sodium glycerophosphate injection, 20 mL vialAI (233 hospitals, 25,538–25,628 samples)
• NDC 00548-9501-00 — Isoproterenol injection, 1 mL vialAI (122 hospitals, 25,538–25,628 samples)
• NDC 60758-0119-10 — Prednisolone acetate 1% eye drops, 10 mL bottleAI (237 hospitals, 24,772–25,627 samples)
• NDC 51672-3020-02 — Lidocaine 5% external ointmentAI (208 hospitals, 24,799–25,627 samples)
• NDC 25021-0107-20 — Ceftriaxone 2 gram injection solutionAI (388 hospitals, 17,899–25,621 samples)
• NDC 00409-9093-45 — Fentanyl injection, 50 mcg per mLAI (151 hospitals, 23,964–25,620 samples)
• NDC 00904-7001-61 — Pregabalin 100 mg capsulesAI (465 hospitals, 25,007–25,619 samples)
• NDC 00527-1947-48 — Lopinavir-ritonavir oral solutionAI (128 hospitals, 24,797–25,607 samples)
• NDC 16729-0422-10 — TACROLIMUS 0.1 % TOPICAL OINTMENTAI (96 hospitals, 24,797–25,607 samples)
• NDC 38779-0364-01 — Beclomethasone dipropionate powderAI (40 hospitals, 24,797–25,607 samples)
• NDC 10019-0553-04 — Scopolamine transdermal patch, 3-dayAI (434 hospitals, 24,823–25,606 samples)
• NDC 64281-0110-05 — Methacholine inhalation solution for breathing testAI (292 hospitals, 25,039–25,606 samples)
• NDC 00904-6364-45 — Divalproex extended-release 500 mg tabletsAI (132 hospitals, 25,261–25,603 samples)
• NDC 00121-0646-16 — Amantadine oral liquid medicineAI (586 hospitals, 25,062–25,602 samples)
• NDC 65302-0503-04 — Labetalol 20 mg intravenous syringeAI (86 hospitals, 24,610–25,600 samples)
• NDC 64980-0448-01 — Neomycin, polymyxin, and hydrocortisone ear dropsAI (215 hospitals, 24,641–25,595 samples)
• NDC 69374-0902-05 — Neostigmine methylsulfate injection, 5 mg/5 mL syringeAI (286 hospitals, 24,829–25,594 samples)
• NDC 50742-0505-24 — Scopolamine 1 mg transdermal patchAI (489 hospitals, 24,550–25,594 samples)
• NDC 49281-0574-15 — Nirsevimab injection for infantsAI (507 hospitals, 25,215–25,593 samples)
• NDC 00338-1144-03 — Clinimix E with dextrose intravenous solutionAI (264 hospitals, 25,384–25,582 samples)
• NDC 71506-0046-45 — Labetalol 20 mg/4 mL IV syringeAI (135 hospitals, 24,608–25,580 samples)
• NDC 70860-0701-04 — Ketorolac injection 60 mg per 2 mLAI (133 hospitals, 24,793–25,576 samples)
• NDC 70700-0167-22 — Glycopyrrolate injection, 0.2 mg/mLAI (195 hospitals, 24,693–25,575 samples)
• NDC 50383-0667-30 — Lidocaine-prilocaine 2.5% numbing creamAI (213 hospitals, 24,746–25,574 samples)
• NDC 24208-0299-05 — Loteprednol 0.5% eye drop suspensionAI (309 hospitals, 24,720–25,557 samples)
• NDC 00378-8700-06 — ACYCLOVIR 5 % TOPICAL OINTMENTAI (191 hospitals, 24,637–25,555 samples)
• NDC 76045-0104-10 — Ketorolac tromethamine 30 mg/mL injectionAI (257 hospitals, 24,604–25,549 samples)
• NDC 67457-0162-00 — Sodium tetradecyl sulfate 1% injectionAI (222 hospitals, 24,700–25,546 samples)
• NDC 00024-5914-01 — Dupixent 300 mg/2 mL subcutaneous injectionAI (309 hospitals, 24,653–25,544 samples)
• NDC 00168-0089-15 — Nystatin and triamcinolone topical ointmentAI (133 hospitals, 24,722–25,541 samples)
• NDC 00456-4300-01 — Fosfomycin 3 gram oral packetAI (292 hospitals, 25,153–25,540 samples)
• NDC 59762-3744-01 — Clindamycin 1% topical lotionAI (194 hospitals, 24,680–25,535 samples)
• NDC 71266-2001-08 — Succinylcholine injection, 20 mg/mL, 10 mL prefilled syringeAI (90 hospitals, 25,321–25,528 samples)
• NDC 00168-0040-46 — BETAMETHASONE VALERATE 0.1 % TOPICAL CREAMAI (109 hospitals, 24,717–25,527 samples)
• NDC 00168-0056-46 — BETAMETHASONE DIPROPIONATE 0.05 % TOPICAL OINTMENTAI (119 hospitals, 24,717–25,527 samples)
• NDC 16714-0245-30 — MESALAMINE 1,000 MG RECTAL SUPPOSITORYAI (148 hospitals, 24,652–25,516 samples)
• NDC 69097-0859-02 — Terbinafine 250 mg tabletsAI (290 hospitals, 25,105–25,510 samples)
• NDC 66993-0490-84 — Intravenous ibuprofen lysine injectionAI (185 hospitals, 24,787–25,507 samples)
• NDC 81284-0831-05 — Physostigmine salicylate injectionAI (145 hospitals, 24,787–25,507 samples)
• NDC 45802-0472-65 — Hydrocortisone and pramoxine rectal creamAI (106 hospitals, 24,632–25,505 samples)
• NDC 00409-3380-31 — Sufentanil citrate injection (IV)AI (37 hospitals, 25,216–25,504 samples)
• NDC 23155-0486-01 — verapamil 120 mg tabletAI (526 hospitals, 24,916–25,501 samples)
• NDC 99999-0001-46 — HEPARIN 1000 UNIT/NS 500 ML ONE-STEP (9 hospitals, 25,500 samples)
• NDC 70069-0013-25 — Glycopyrrolate 0.2 mg/mL injectionAI (148 hospitals, 24,644–25,499 samples)